Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based therapy for Pulmonary Hypertension: MiRNA-302b inhibits pulmonary hypertension via down regulation of its target genes, 21/January/2015, 19.05, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-302b, by increasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “MiRNA-302b or its activators” may be used to treat pulmonary hypertension.
Amount: $ 300
Undisclosed information: How MiRNA-302b inhibits the development of pulmonary hypertension
Courtesy: When you cite drop us a line at firstname.lastname@example.org